查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1839059

細胞分離/細胞分離市場（按產品、技術、細胞類型、應用和最終用戶）—全球預測 2025-2032

Cell Isolation/Cell Separation Market by Product, Technology, Cell Type, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，細胞分離/細胞分離市場將成長至 392.5 億美元，複合年成長率為 14.88%。

主要市場統計數據
基準年2024年 129.3億美元
預計2025年 148.4億美元
預測年份：2032年 392.5億美元
複合年成長率（%） 14.88%

核心細胞分離技術、不斷變化的最終用戶優先事項以及影響轉化研究和臨床流程的策略考慮的簡要說明

細胞分離和離析技術支撐著從基礎免疫學研究到先進細胞療法製造等廣泛的生命科學研究和臨床應用。儀器和試劑的進步正在逐步降低精確單細胞和批量細胞處理的門檻，從而實現更可重複的工作流程並加速轉化路徑。隨著學術團體、生物技術創新者和臨床實驗室日益尋求可擴展且易於自動化的解決方案，可用工具的種類也日益多樣化，以滿足對通量、純度和活力的不同要求。

因此，相關人員不僅要評估技術的分析效能，還要評估其與資料流程、法規遵循框架和下游處理的整合程度。微射流、磁分離和高解析度流式細胞技術與雲端數據分析的融合正在重塑團隊的實驗設計和流程擴展。本簡介將重點介紹核心技術促進因素、不斷變化的最終用戶需求以及在研究、臨床和商業環境中為採購和開發選擇提供參考的戰略考量，從而構成以下章節的框架。

技術融合、自動化和數據支援的工作流程如何重新定義細胞分離並重塑供應商與最終用戶之間的動態

技術融合和不斷變化的應用需求共同改變了細胞​​分離的模式。最初的改進主要集中在透過改進試劑和提高靈敏度的流式細胞儀來提高細胞純度和回收率。最近，自動化樣品處理和計算分析的整合帶來了最深刻的變化。

此外，更溫和的分離方式的開發，例如奈米材料增強磁珠和旨在保留細胞表現型的微流體平台，為幹細胞和原代免疫群體等精細細胞類型開闢了新的可能性。因此，曾經需要專業知識的工作流程現在可供更廣泛的最終用戶使用。同時，競爭力量正推動供應商將耗材與服務模式和軟體捆綁在一起，建立生態系統並加速採用，但也引發了對供應商鎖定和資料互通性的擔憂。這種轉變促使實驗室和主要企業重新評估其採購標準，重點關注營運連續性、數據完整性以及將分離細胞輸出轉化為下游檢測和療法的能力。

評估 2025 年美國關稅調整如何改變整個電池分離生態系統的採購、供應鏈策略和製造商採購決策

美國近期宣布的2025年關稅調整帶來了新的變量，將影響細胞分離領域的籌資策略、供應鏈彈性和跨境合作。設備和專用試劑的進口關稅上調將增加到岸成本，迫使實驗室採購團隊重新評估採購時機、供應商選擇和庫存策略。因此，各機構需要在短期成本壓力與更換供應商或採用工作流程可能尚未完全檢驗的替代技術所帶來的長期營運風險之間取得平衡。

除了影響價格外，關稅還會影響供應商的行為和投資決策。一些製造商正在透過擴大生產區域、實現零件採購多元化或調整分銷模式來應對關稅的影響。這些調整可能會為依賴一致試劑批次或儀器零件相容性的客戶帶來過渡摩擦。由於關稅分類變化而加劇的監管和海關延誤，也延長了前置作業時間，並使即時庫存方法變得複雜。為了因應這種環境，企業越來越重視多源採購策略，並與供應商建立密切合作，以確保供應的連續性，並在貿易政策變化的情況下保持實驗的可重複性。

全面的細分主導洞察，將產品類型、實行技術、細胞類型和最終用戶優先級聯繫起來，為採購和開發決策提供訊息

要了解市場動態，需要明確多個細分維度以及每個類別對買家和開發者的實際意義。在耗材領域，拋棄式和試劑決定了每次運行的經濟性和檢測的一致性，而數據分析軟體和維護服務則決定了生命週期價值和執行時間。同時，流式細胞技術、磁珠和微射流支援更高的解析度和精準的應用。流式細胞技術本身又分為分析型細胞儀和分選型細胞儀，磁珠技術因規模而異，從大珠到奈米珠，每種技術在結合動力學和細胞回收率方面都有各自的優缺點。

B 細胞、T 細胞、樹突狀細胞、幹細胞和癌細胞對維持活力、純度閾值和下游適用性都有不同的要求。同時，感染疾病和產前檢測優先考慮速度、診斷靈敏度和監管可追溯性。最後，最終用戶的細分凸顯了其營運的多樣性：學術研究機構優先考慮實驗靈活性和成本效益；生物技術和製藥公司重視擴充性和監管合規性；委外研發機構重視通量、可重複性和客戶報告；醫院和診所需要臨床級可靠性以及與患者照護途徑的整合。這些細分視角共同構成了一幅細緻入微的需求圖，創新者和負責人在評估技術和夥伴關係時必須考慮。

影響美洲、歐洲、中東和非洲地區以及亞太地區的招募速度、供應商策略和監管協調的區域動態和基礎設施考量

每個地區的動態對技術採用、供應商策略和監管參與提出了不同的要求。在美洲，轉化研究的投資和細胞療法製造中心的成長，推動了對符合GMP標準的設備、檢驗的耗材以及支援規模化生產的強大服務模式的需求。同時，歐洲、中東和非洲呈現出一種多元化的格局，成熟的研究中心與新興的臨床市場並存。在這裡，監管的細微差別和報銷途徑決定了採用時間表，與當地經銷商的夥伴關係通常決定了市場進入和支援品質。

亞太地區產能擴張迅猛，國內創新不斷加強，國內供應商數量不斷成長，持續成為重要的製造能力中心，用戶群也迅速擴張。這種區域性成長往往會加劇價格競爭，並刺激區域服務網路的發展。在所有地區，標準的統一性、訓練有素的人才儲備以及物流基礎設施將影響新型分離技術從試點應用到常規部署的速度，因此區域策略將成為商業和營運規劃的核心。

競爭定位、平台整合和不斷發展的服務模式如何塑造供應商策略並在細胞分離領域創造差異化的價值提案

供應商之間的競爭日益由產品創新、平台整合和商業合作模式的結合所定義。領先的公司正在擴展其產品組合，將儀器與專有耗材和軟體分析相結合，以確保長期經常性收益並提升用戶體驗。此外，儀器供應商和軟體開發商之間的策略聯盟加速了端到端工作流程，縮短了從樣本到洞察的路徑。同時，專業供應商繼續透過利基產品實現差異化，例如用於幹細胞的溫和分離技術或用於腫瘤學應用的高速分選器，為重點創新和廣泛的平台整合騰出空間。

對於需要可預測正常運作的臨床和大規模製造客戶來說，維護合約、遠距離診斷和培訓計畫已成為特別重要的價值因素。併購活動反映出一個市場，在這個市場中，專業知識的規模和深度都至關重要，同時對特定應用研發的選擇性投資也至關重要。對於決策者而言，能夠證明工作流程檢驗、法規支援以及與下游檢測和資料生態系統的互通性正在成為競爭優勢。

領導者應採取指南，增強供應彈性，加速採用檢驗的技術，並整合資料互通性，以實現可擴展的細胞分離工作流程

產業領導者應採用投資組合方法，在短期營運彈性和長期創新投資之間取得平衡。首先，優先考慮多方採購和庫存緩衝，以緩解供應鏈衝擊和關稅造成的成本波動，同時協商合約條款，確保批次可追溯性和品質保證。其次，投資可互通的數據平台和檢驗的分析方法，以實現跨供應商整合，並加速將分離結果轉化為下游檢測和製造流程。這些投資可以減少協作研究過程中的摩擦，並支持分散式團隊獲得可重複的結果。

同時，各機構應評估在需要溫和處理和單細胞解析度的工作流程中試行自動化和微流體解決方案的機會，並透過分階段的檢驗計劃降低採用風險。與供應商建立密切的夥伴關係，共同開發特定應用的套件和服務協議，可以縮短驗證週期並降低整體擁有成本。最後，致力於人才培養，透過有針對性的培訓計劃來提高操作員的熟練程度和儀器的運作，並將監管準備計劃納入早期開發里程碑，以簡化臨床和商業化路徑。

一種透明的、多來源的調查方法，結合相關人員訪談、技術文獻綜述和交叉檢驗，以產生可操作且可辯護的見解

本分析背後的調查方法結合了多元化的依證，以確保得出穩健且可複製的結論。主要研究包括對實驗室主任、採購專員、設備工程師和臨床營運負責人的結構化訪談，以了解研究和臨床環境中的營運現狀和應用促進因素。次要研究包括官方監管文件、同行評審文獻和製造商技術規範，以檢驗性能聲明並了解監管限制和檢驗要求。整合這些資訊來源，以確定主題趨勢、技術曲折點以及最終用戶使用的實際決策標準。

透過跨資料類型交叉檢驗、將定性見解與已發表的技術基準進行三角檢驗以及敏感性檢查，確保分析的嚴謹性，從而確保在不同操作假設下結論的一致性。我們強調假設的透明度，並記錄了需要仔細解讀的稀缺數據領域，例如早期微流體平台和專有試劑配方。本調查方法支持實踐指南，同時認知到現有資訊的局限性和技術進步的動態性。

趨勢摘要強調互通性、供應彈性和勞動力準備度是提供可擴展和可重複的細胞分離結果的關鍵因素

摘要，細胞分離和離析技術在技術改進、服務導向的商業模式以及區域差異化應用路徑的共同作用下不斷發展。最重要的趨勢包括向資料整合工作流程的轉變、針對敏感細胞類型的更溫和的分離方法的成熟，以及在關稅和物流壓力下，彈性供應鏈的重要性日益提升。最終用戶現在不僅關注儀器性能，還關注生命週期服務、軟體互通性和法規遵從性。

展望未來，重視互通性、供應商協作和員工能力的組織將最有能力將其分離能力轉化為下游研究和臨床價值。雖然技術選擇會因細胞類型和應用而異，但策略重點很明確：協調投資，以實現可重複、可擴展的工作流程，使其能夠順利融入分析和製造生態系統，從而加速科學和治療成果的實現。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 基於微流體的無標定細胞分離平台整合，用於高通量分選
  • 以微珠為基礎磁珠的自動免疫磁分離系統在臨床細胞治療生產的應用
  • 新興的無標定聲學和介電泳技術，用於大規模、溫和的活細胞分選
  • 微流體分離與單細胞多組體學工作流程結合，用於精準醫學研究
  • 將人工智慧應用於基於影像的細胞分選以提高特異性和吞吐量

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

8. 細胞分離/細胞分離市場（依產品）

  • 耗材
    • 一次性的
    • 試劑
  • 裝置
  • 套件
  • 軟體和服務
    • 數據分析軟體
    • 維護服務

9. 細胞分離/細胞分離市場（依技術）

  • 離心
  • 濾
  • 流式細胞技術
    • 分析細胞計數法
    • 分選流式細胞儀
  • 磁珠
    • 大珠
    • 奈米珠
  • 微流體

10. 細胞分離/細胞分離市場（依細胞類型）

  • B細胞
  • 癌細胞
  • 樹突狀細胞
  • 幹細胞
  • T細胞

第 11 章。細胞分離/細胞分離市場（依應用）

  • 細胞療法
  • 免疫學
  • 感染疾病
  • 腫瘤學
  • 產前檢查
  • 幹細胞研究

第 12 章：細胞分離/細胞分離市場（依最終用戶）

  • 學術研究機構
  • 生物技術和製藥公司
  • 合約研究組織
  • 醫院和診所

13. 細胞分離/細胞分離市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第 14 章。細胞分離/細胞分離市場（按組）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 細胞分離/細胞分離市場（依國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Thermo Fisher Scientific Inc
    • Becton, Dickinson and Company
    • Danaher Corporation
    • Beckman Coulter, Inc
    • Bio-Rad Laboratories, Inc
    • Agilent Technologies, Inc
    • Merck KGaA
    • Lonza Group AG
    • Sartorius AG
    • Terumo Corporation
Product Code: MRR-034230D3E62F

The Cell Isolation/Cell Separation Market is projected to grow by USD 39.25 billion at a CAGR of 14.88% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 12.93 billion
Estimated Year [2025] USD 14.84 billion
Forecast Year [2032] USD 39.25 billion
CAGR (%) 14.88%

A concise orientation to core cell isolation technologies, evolving end-user priorities, and the strategic considerations shaping translational research and clinical pipelines

Cell isolation and separation technologies underpin a broad spectrum of life sciences research and clinical applications, from basic immunology studies to advanced cell therapy manufacturing. Advances in instrumentation and reagents have progressively lowered barriers to precise single-cell and bulk-cell processing, enabling more reproducible workflows and accelerating translational pathways. As academic groups, biotech innovators, and clinical laboratories increasingly demand scalable and automation-friendly solutions, the landscape of available tools has diversified to meet divergent throughput, purity, and viability requirements.

In consequence, stakeholders must evaluate technologies not only for analytical performance but also for their integration into data pipelines, regulatory compliance frameworks, and downstream processing. The convergence of microfluidics, magnetic separation, and high-resolution flow cytometry with cloud-enabled data analysis is reshaping how teams design experiments and scale processes. This introduction frames the subsequent sections by highlighting core technological drivers, evolving end-user needs, and the strategic considerations that inform procurement and development choices across research, clinical, and commercial settings.

How technological convergence, automation, and data-enabled workflows are redefining cell isolation practices and reshaping supplier and end-user dynamics

The landscape of cell isolation has experienced transformative shifts driven by both technology convergence and evolving application demands. Initially, improvements centered on enhancing cell purity and recovery through refined reagents and more sensitive cytometric instrumentation. More recently, the most consequential changes have arisen from the integration of automated sample handling and computational analysis, which together enable reproducible processing at scales previously unattainable for many laboratories.

Moreover, the development of gentle separation modalities - including nanomaterial-enhanced magnetic beads and microfluidic platforms designed to preserve cell phenotype - has opened new possibilities for delicate cell types such as stem cells and primary immune populations. As a result, workflows that once required specialist expertise are becoming accessible to a broader set of end users. Simultaneously, competitive dynamics have pushed providers to bundle consumables with service models and software, creating ecosystems that accelerate adoption but also raise considerations around vendor lock-in and data interoperability. These shifts are leading laboratories and companies to reassess procurement criteria with greater emphasis on operational continuity, data integrity, and the ability to translate isolated-cell outputs into downstream assays and therapies.

Assessing how 2025 United States tariff adjustments are altering procurement, supply chain strategies, and manufacturer sourcing decisions across the cell separation ecosystem

Recent tariff changes announced by the United States for 2025 have introduced new variables that affect procurement strategies, supply chain resiliency, and cross-border collaboration in the cell isolation domain. Tariff activity has a cascading effect: increased import levies on instruments and specialized reagents heighten landed costs, which in turn requires laboratory procurement teams to re-evaluate purchase timing, vendor selection, and inventory strategies. Consequently, organizations are balancing short-term cost pressures with longer-term operational risks associated with substituting suppliers or switching to alternate technologies that may not yet be fully validated for their workflows.

In addition to price implications, tariffs influence supplier behavior and investment decisions. Some manufacturers respond by regionalizing production, diversifying component sourcing, or adjusting their distribution models to mitigate exposure. These adjustments can create transitional friction for customers who rely on consistent reagent lots and instrument part compatibility. Regulatory and customs delays, amplified by changed tariff classifications, also extend lead times and complicate just-in-time inventory approaches. To navigate this environment, organizations are increasingly prioritizing multi-sourcing strategies and establishing closer collaborations with vendors to secure supply continuity and maintain experimental reproducibility despite evolving trade policies.

Comprehensive segmentation-driven insights linking product categories, enabling technologies, cell types, and end-user priorities to inform procurement and development decisions

Understanding market dynamics requires clarity across multiple segmentation axes and the practical implications of each category for buyers and developers. From a product perspective, stakeholders differentiate among consumables, instruments, kits, and software and services; within consumables, disposables and reagents determine per-run economics and assay consistency, while data analysis software and maintenance services shape lifecycle value and uptime. Transitioning from product to technology, techniques such as centrifugation and filtration remain foundational for bulk separations, whereas flow cytometry, magnetic beads, and microfluidics support higher-resolution and targeted applications; the flow cytometry category itself divides between analytical cytometry and sorting cytometry, and magnetic bead technologies vary by scale from macro beads to nano beads, each offering trade-offs in binding kinetics and cell recovery.

Equally important is cell type segmentation, which directs technology choice: B cells, T cells, dendritic cells, stem cells, and cancer cells each impose distinct requirements for viability preservation, purity thresholds, and downstream compatibility. Application segmentation further refines priorities because cell therapy and stem cell research demand gentle, GMP-aligned workflows, while infectious disease and prenatal testing place premium value on speed, diagnostic sensitivity, and regulatory traceability. Finally, end-user segmentation highlights operational diversity: academic and research institutes prioritize experimental flexibility and cost-efficiency; biotech and pharma companies focus on scalability and regulatory alignment; contract research organizations emphasize throughput, reproducibility, and client reporting; and hospitals and clinics require clinical-grade reliability and integration with patient-care pathways. Together, these segmentation lenses create a nuanced map of requirements that innovators and purchasers must navigate when evaluating technologies and partnerships.

Regional dynamics and infrastructure considerations that influence the adoption pace, supplier strategies, and regulatory alignment across the Americas, EMEA, and Asia-Pacific

Regional dynamics impart distinct imperatives for technology adoption, supplier strategies, and regulatory alignment. In the Americas, investment in translational research and the growth of cell therapy manufacturing hubs drive demand for GMP-compatible instruments, validated consumables, and robust service models that support scale-up. Meanwhile, Europe, Middle East & Africa present a heterogeneous picture in which well-established research centers coexist with emerging clinical markets; here, regulatory nuance and reimbursement pathways shape adoption timelines, and partnerships with local distributors often determine market access and support quality.

Asia-Pacific continues to be a major locus of manufacturing capability and a rapidly expanding user base, characterized by aggressive capacity building, increasing domestic innovation, and growing domestic suppliers. This regional push frequently accelerates price competition and stimulates the development of localized service networks. Across all regions, harmonization of standards, the availability of trained personnel, and logistics infrastructure affect how quickly new separation technologies move from pilot use to routine deployment, making regional strategies central to commercial and operational planning.

How competitive positioning, platform integration, and evolving service models are shaping supplier strategies and creating differentiated value propositions in cell separation

Competitive activity among suppliers is increasingly defined by a mix of product innovation, platform integration, and commercial partnership models. Leading firms are expanding portfolios to couple instruments with proprietary consumables and software analytics to lock in long-term recurring revenue and improve user experience. Additionally, strategic alliances between instrument vendors and software developers accelerate end-to-end workflows that shorten the path from sample to insight. On the other hand, specialist providers continue to differentiate through niche offerings such as gentle isolation technologies for stem cells or high-speed sorters for oncology applications, preserving space for focused innovation alongside broader platform consolidation.

Service propositions are also evolving: maintenance contracts, remote diagnostics, and training programs have become essential elements of value, particularly for clinical and large-scale manufacturing customers who require predictable uptime. Mergers and acquisition activity, along with selective investments in application-specific R&D, reflect a marketplace where scale and depth of expertise both matter. For decision-makers, competitive positioning increasingly hinges on the ability to demonstrate validated workflows, regulatory support, and proven interoperability with downstream assays and data ecosystems.

Actionable pathways for leaders to strengthen supply resilience, accelerate validated technology adoption, and embed data interoperability for scalable cell separation workflows

Industry leaders should adopt a portfolio approach that balances near-term operational resilience with long-term innovation investments. First, prioritize multi-sourcing and inventory buffering to mitigate supply chain shocks and tariff-driven cost volatility, while negotiating contractual terms that preserve lot traceability and quality assurance. Second, invest in interoperable data platforms and validated analytics to enable cross-vendor integration and accelerate the translation of isolation outputs into downstream assays and manufacturing steps. These investments reduce friction during collaborations and support reproducible outcomes across distributed teams.

Concurrently, organizations should evaluate opportunities to pilot automation and microfluidic solutions for workflows that demand gentle handling or single-cell resolution, using staged validation plans to de-risk adoption. Building closer partnerships with suppliers to co-develop application-specific kits and service agreements can shorten validation cycles and improve total cost of ownership. Finally, commit to workforce development through targeted training programs that enhance operator proficiency and instrument uptime, and incorporate regulatory-readiness planning into early development milestones to streamline clinical translation and commercialization pathways.

A transparent, multi-source research methodology blending stakeholder interviews, technical literature review, and cross-validation to produce actionable and defensible insights

The research methodology underpinning this analysis combined a multi-pronged evidence base to ensure robust, reproducible conclusions. Primary inputs included structured interviews with laboratory directors, procurement specialists, instrument engineers, and clinical operations leaders to capture operational realities and adoption drivers across research and clinical settings. Secondary inputs encompassed public regulatory documents, peer-reviewed literature, and manufacturer technical specifications to validate performance claims and to understand regulatory constraints and validation requirements. These sources were synthesized to identify thematic trends, technology inflection points, and practical decision criteria used by end users.

Analytical rigor was maintained through cross-validation across data types, triangulation of qualitative insights with published technical benchmarks, and sensitivity checks to ensure conclusions remained consistent under varying operational assumptions. Emphasis was placed on transparency in assumptions and on documenting areas where data scarcity necessitated cautious interpretation, such as nascent microfluidic platforms or proprietary reagent formulations. This methodological approach supports actionable guidance while acknowledging the limits of available information and the dynamic nature of technological advancement.

Concluding synthesis of trends emphasizing interoperability, supply resilience, and workforce readiness as the critical enablers of scalable and reproducible cell isolation outcomes

In summary, cell isolation and separation continue to evolve through a combination of technological refinement, service-oriented commercial models, and regionally distinct adoption pathways. The most consequential trends are the shift toward data-integrated workflows, the maturation of gentle separation modalities for sensitive cell types, and the increasing importance of resilient supply chains in the face of tariff and logistics pressures. These forces collectively reshape procurement criteria, where end users now place comparable emphasis on lifecycle service, software interoperability, and regulatory compatibility as they do on raw instrument performance.

Looking ahead, organizations that prioritize interoperability, supplier collaboration, and workforce capability will be best positioned to translate isolation capabilities into downstream research and clinical value. While technology selection will remain contingent on cell type and application, the broader strategic emphasis is clear: align investments to enable reproducible, scalable workflows that integrate smoothly into analytical and manufacturing ecosystems, thereby accelerating scientific and therapeutic outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of microfluidic-based label-free cell separation platforms for high-throughput sorting
  • 5.2. Adoption of automated magnetic bead-based immunomagnetic separation systems for clinical cell therapy manufacturing
  • 5.3. Emergence of label-free acoustic and dielectrophoretic techniques for gentle viable cell sorting at scale
  • 5.4. Integration of single-cell multiomics workflows with microfluidic isolation for precision medicine research
  • 5.5. Application of artificial intelligence-driven image-based cell sorting to enhance specificity and throughput

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cell Isolation/Cell Separation Market, by Product

  • 8.1. Consumables
    • 8.1.1. Disposables
    • 8.1.2. Reagents
  • 8.2. Instruments
  • 8.3. Kits
  • 8.4. Software And Services
    • 8.4.1. Data Analysis Software
    • 8.4.2. Maintenance Services

9. Cell Isolation/Cell Separation Market, by Technology

  • 9.1. Centrifugation
  • 9.2. Filtration
  • 9.3. Flow Cytometry
    • 9.3.1. Analytical Cytometry
    • 9.3.2. Sorting Cytometry
  • 9.4. Magnetic Beads
    • 9.4.1. Macro Beads
    • 9.4.2. Nano Beads
  • 9.5. Microfluidics

10. Cell Isolation/Cell Separation Market, by Cell Type

  • 10.1. B Cells
  • 10.2. Cancer Cells
  • 10.3. Dendritic Cells
  • 10.4. Stem Cells
  • 10.5. T Cells

11. Cell Isolation/Cell Separation Market, by Application

  • 11.1. Cell Therapy
  • 11.2. Immunology
  • 11.3. Infectious Diseases
  • 11.4. Oncology
  • 11.5. Prenatal Testing
  • 11.6. Stem Cell Research

12. Cell Isolation/Cell Separation Market, by End User

  • 12.1. Academic And Research Institutes
  • 12.2. Biotech And Pharma Companies
  • 12.3. Contract Research Organizations
  • 12.4. Hospitals And Clinics

13. Cell Isolation/Cell Separation Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Cell Isolation/Cell Separation Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Cell Isolation/Cell Separation Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Thermo Fisher Scientific Inc
    • 16.3.2. Becton, Dickinson and Company
    • 16.3.3. Danaher Corporation
    • 16.3.4. Beckman Coulter, Inc
    • 16.3.5. Bio-Rad Laboratories, Inc
    • 16.3.6. Agilent Technologies, Inc
    • 16.3.7. Merck KGaA
    • 16.3.8. Lonza Group AG
    • 16.3.9. Sartorius AG
    • 16.3.10. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. CELL ISOLATION/CELL SEPARATION MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. CELL ISOLATION/CELL SEPARATION MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CELL ISOLATION/CELL SEPARATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DISPOSABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DISPOSABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DISPOSABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DISPOSABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DISPOSABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DISPOSABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAINTENANCE SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAINTENANCE SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAINTENANCE SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAINTENANCE SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CENTRIFUGATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CENTRIFUGATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CENTRIFUGATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CENTRIFUGATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CENTRIFUGATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CENTRIFUGATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FILTRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FILTRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FILTRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FILTRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FILTRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FILTRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ANALYTICAL CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ANALYTICAL CYTOMETRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ANALYTICAL CYTOMETRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ANALYTICAL CYTOMETRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ANALYTICAL CYTOMETRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ANALYTICAL CYTOMETRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SORTING CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SORTING CYTOMETRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SORTING CYTOMETRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SORTING CYTOMETRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SORTING CYTOMETRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SORTING CYTOMETRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MACRO BEADS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MACRO BEADS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MACRO BEADS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MACRO BEADS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MACRO BEADS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MACRO BEADS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY NANO BEADS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY NANO BEADS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY NANO BEADS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY NANO BEADS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY NANO BEADS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY NANO BEADS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MICROFLUIDICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MICROFLUIDICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MICROFLUIDICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MICROFLUIDICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY B CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY B CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY B CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY B CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY B CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY B CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CANCER CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CANCER CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CANCER CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CANCER CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CANCER CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CANCER CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DENDRITIC CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DENDRITIC CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DENDRITIC CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DENDRITIC CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DENDRITIC CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DENDRITIC CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY STEM CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY STEM CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY STEM CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY STEM CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY STEM CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY T CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY T CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY T CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY T CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY T CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY T CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY IMMUNOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY IMMUNOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY IMMUNOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY IMMUNOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRENATAL TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRENATAL TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRENATAL TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRENATAL TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY STEM CELL RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY STEM CELL RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY STEM CELL RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY STEM CELL RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY BIOTECH AND PHARMA COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY BIOTECH AND PHARMA COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY BIOTECH AND PHARMA COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY BIOTECH AND PHARMA COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY BIOTECH AND PHARMA COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY BIOTECH AND PHARMA COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2024 (USD MILLION)